Curcumin for Rheumatoid Arthritis

Verdict: Published with Warning

Across 5 PubMed studies, the evidence for Curcumin in Rheumatoid Arthritis grades Tier B — preliminary evidence. Effective, but with safety or population caveats.

B 🟡 B Preliminary Evidence Published with Warning

🔬Why this grade7-layer evidence engine

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.63
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
B · Published with Warning
Confidence
79%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L1 ExamineGlobal benchmark
0.50
L5 Clinical bodiesAuthoritative stance
0.50
L3 MechanismPlausibility
0.65
L11 AI re-checkIndependent read
0.65
L2 PubMedPrimary literature
0.75
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.627
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (4 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Curcumin for the clinical treatment of rheumatoid arthritis: a systematic review and meta-analysis of placebo-controlled randomized clinical trials
PMID: 41601662 2025 統合分析 n = 244
Finding: Curcumin significantly improved ACR20 (SMD 4.35, 95% CI 2.22 to 6.47, P<0.0001) and DAS-28 (SMD -3.40, 95% CI -5.29 to -1.50, P=0.0004), but GRADE-rated certainty was very low for nearly all outcomes (only RF was low).
Academic Effect size: DAS-28 SMD -3.40 (95% CI -5.29 to -1.50); ACR20 SMD 4.35 (95% CI 2.22 to 6.47); all outcomes GRADE 'very low' certainty except RF ('low')
View on PubMed
Effect of curcumin on inflammatory markers and disease activity in patients with rheumatoid arthritis: A meta-analysis
PMID: 41327719 2025 統合分析
Finding: Across 7 RCTs, curcumin significantly reduced DAS28 (WMD -1.47, 95% CI -1.68 to -1.26), RF (WMD -24.15, 95% CI -36.47 to -11.83), ESR (WMD -31.26, 95% CI -58.59 to -3.93) and CRP (WMD -0.93, 95% CI -1.33 to -0.53), with high heterogeneity but no significant publication bias on Egger test.
Academic Effect size: DAS28 WMD -1.47 (95% CI -1.68 to -1.26); CRP WMD -0.93 (95% CI -1.33 to -0.53); substantial heterogeneity, stable on leave-one-out
View on PubMed
Effect of curcumin on rheumatoid arthritis: a systematic review and meta-analysis
PMID: 37325651 2023 統合分析 n = 539
Finding: Across 6 studies (539 patients) curcumin significantly reduced DAS28 (MD -1.20, 95% CI -1.85 to -0.55, P=0.0003), ESR (MD -29.47, 95% CI -54.05 to -4.88, P=0.02), SJC (MD -5.33, P=0.02) and TJC (MD -6.33, P=0.006).
Academic Effect size: DAS28 MD -1.20 (95% CI -1.85 to -0.55, P=0.0003); ESR MD -29.47 (95% CI -54.05 to -4.88); SJC MD -5.33; TJC MD -6.33
View on PubMed
A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis
PMID: 22407780 2012 RCT (open-label) n = 45
Finding: In 45 active-RA patients randomized to curcumin 500 mg, diclofenac 50 mg, or both, all groups improved DAS28 significantly and the curcumin group showed the greatest improvement in DAS28 and ACR20/50/70, significantly better than diclofenac, with no adverse events (no numeric effect size reported in abstract).
🟠 Limited quality ⚠️ Industry-funded
View on PubMed
Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial
PMID: 35935936 2022 統合分析 n = 2,396
Finding: Across 29 RCTs (2396 participants, 5 arthritis types) curcumin/Curcuma longa (120-1500 mg, 4-36 wks) improved inflammation and pain and was safe, but authors caution conclusions must be interpreted carefully due to low RCT quality and small numbers (no pooled RA-only effect size reported).
🟠 Limited quality Academic
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4b EU EFSA
Cautious
the Panel established an ADI for curcumin of 3 mg/kg bw/day source↗
L4c UK NHS
Cautious
Avoid turmeric and curcumin in individuals with bile duct obstruction, cholangitis, liver disease, gallstones, or any biliary disease. source↗
L4d TW TFDA / 衛福部
Cautious
薑黃素每人每日攝取量為每公斤體重0~3毫克,每日不超過200毫克為宜 source↗
L4e WHO
Neutral
Rhizoma Curcumae Longae source↗
L5a NIH Office of Dietary Supplements
Cautious
We don't know enough to definitively conclude if turmeric or curcumin is beneficial for any health purposes. source↗
L5b Mayo Clinic
Cautious
Curcumin may lessen some of the symptoms of rheumatoid arthritis, such as joint swelling and morning stiffness. One study found that taking turmeric extract three times daily was comparable to taking a 1,200-milligram dose of ibuprofen daily. However, more research is necessary to confirm these effects. source↗
L5c Cleveland Clinic
Supportive
Some studies have shown turmeric to have anti-inflammatory effects. Dr. Rosian says 750 milligrams twice a day, or 1,000 milligrams once a day, is the ideal dose. source↗
L5d Harvard Health
Cautious
Several other herbs and supplements have been evaluated for their ability to reduce inflammation in people with rheumatoid arthritis. These include Boswellia (also called frankincense), ginger, green tea, and turmeric. Research into these compounds is too preliminary to make specific recommendations, however. source↗
L5e Specialty Society (condition-mapped)
Cautious
Turmeric has gained more recent fame in managing pain from osteoarthritis due to its anti-inflammatory and antioxidant properties. Current recommendation is to take curcumin, the active form of turmeric at 500 mg-1000 mg daily. ... While these supplements can be helpful, there is limited data to prove efficacy, and the FDA does not review them, so long-term safety has not been determined. source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-rheumatoid-arthritis-INT-curcumin-001 繁體中文版 →